Procter & Gamble Hygiene and Health Care Ltd
PGHH NSE
Procter & Gamble Hygiene and Health Care Ltd
Fast Moving Consumer GoodsNSE: PGHH BSE: 500459 Personal Products
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.
AI Verdict: HOLD Confidence: 5%
PGHH offers exceptional ROE of 115% and a debt-free balance sheet, but the stock has declined 32% in the past year and trades at an expensive 39.45x book value. With 75% analyst buy ratings but poor sales growth of just 7% over 5 years, the risk-reward is balanced at current levels.
Key Fundamentals
SmallcapPersonal CareConsumer GoodsMarket Cap
₹29,182 Cr
Volatility
Moderate
P/E Ratio
34.19
EBITDA
₹1,162 Cr
Return on Equity
71.68%
Debt to Equity
0
Book Value
₹232.12
EPS
₹229.57
52W High
₹14,540
52W Low
₹8,883.5
Technical Indicators
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 89.4%
- Company has been maintaining a healthy dividend payout of 91.5%
Weaknesses
2- Stock is trading at 38.7 times its book value
- The company has delivered a poor sales growth of 7.40% over past five years.
Growth Rate
Revenue Growth
25.49% ↗
Net Income Growth
35.54% ↗
Cash Flow Change
26.21% ↗
ROE
-0.85% ↘
ROCE
-6.71% ↘
EBITDA Margin (Avg.)
0.94% ↗
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 1d agoHOLD
Risk medium
PGHH offers exceptional ROE of 115% and a debt-free balance sheet, but the stock has declined 32% in the past year and trades at an expensive 39.45x book value. With 75% analyst buy ratings but poor sales growth of just 7% over 5 years, the risk-reward is balanced at current levels.
Bull Case 8
- Exceptional return on equity of 115% in the last year, with a 3-year average ROE of 89%, indicating highly efficient capital allocation
- Company is virtually debt-free, providing strong financial resilience and flexibility for future investments
- TTM sales growth has accelerated sharply to 27%, signaling potential turnaround in topline momentum
- Compounded profit growth of 35% TTM demonstrates strong operating leverage and margin expansion
- Healthy dividend payout ratio of 91.5% with a current dividend yield of 2.13%, attractive for income investors
- 75% of analysts (3 out of 4) have a buy rating on the stock, reflecting positive institutional sentiment
- Long-term compounded profit CAGR of 15% over 5 years outpaces sales growth of 7%, showing consistent margin improvement
- Backed by Procter & Gamble global parentage, providing strong brand equity and R&D pipeline in hygiene and health care segments
Bear Case 8
- Stock has declined 32% over the past 1 year, significantly underperforming the broader market
- Trading at 39.45x price-to-book value, one of the most expensive valuations in the FMCG sector
- PE ratio of 34.7x is elevated given the modest 5-year sales CAGR of only 7%
- 3-year stock price CAGR of -14% indicates sustained value destruction for medium-term investors
- 5-year compounded sales growth of just 7% reflects poor topline expansion in a high-growth Indian consumer market
- 10-year stock CAGR of only 4% suggests the stock has chronically underperformed equity benchmarks over the long term
- Market cap of Rs 29,758 Cr with limited product portfolio concentration in feminine hygiene and health care narrows the addressable market
- 3-year sales CAGR of just 3% prior to TTM acceleration raises questions about sustainability of the recent 27% topline surge
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 14h ago Positives 3
- FY26 net profit up 34.5% May 28
P&G Hygiene reported FY26 net profit of ₹8,565 crore, up 34.5% YoY, with revenue at ₹42,904 crore.
- ₹86 cr productivity savings Jun 16
P&G Hygiene announced INR 86 crore in productivity savings for FY 25/26, indexed against a 12-month period due to fiscal year change.
- Rs 60 per share dividend Jun 22
Board recommended a final dividend of Rs 60 per share for FY26, subject to AGM approval on August 24, 2026. Record date is August 17, 2026.
Neutral 5
- New CFO appointed from July May 28
Srividya Srinivasan appointed Executive Director and CFO effective July 1, 2026, replacing outgoing CFO Gaurav Bhartia and Company Secretary Ghanashyam Hegde.
- Mohit Pradhan named VP Jun 12
Mohit Pradhan appointed Vice President and Category Leader effective Aug 1, 2026, replacing Girish Kalyanaraman.
- Promoter holds 51.82% unencumbered Jun 23
Procter & Gamble Overseas India B.V. holds 86,01,071 shares (51.82%) with no encumbrance as of March 31, 2026.
- TTIPL transfers 1.91% to PGHPPL Jun 19
Temple Trees Impex transferred 6,19,683 shares to Procter & Gamble Home Products on June 18, 2026, worth ₹557.43 crore.
- Analyst meet held June 16 Jun 3
P&G Hygiene held a virtual connect for analysts and institutional investors on June 16, 2026.
TL;DR: P&G Hygiene delivered a strong FY26 with 34.5% profit growth and meaningful productivity savings, signalling solid operational execution. The Rs 60 dividend reflects confidence in cash generation. No material headwinds are visible in recent news flow. With leadership transitions underway and clean promoter holding, the near-term outlook remains constructive.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 883 | 853 | 1,138 | 1,133 | 1,002 | 932 | 1,135 | 1,248 | 992 | 937 | 1,150 | 1,262 | 941 |
| Expenses | 734 | 638 | 853 | 824 | 745 | 813 | 845 | 877 | 782 | 671 | 865 | 860 | 723 |
| Operating Profit | 149 | 215 | 285 | 310 | 257 | 118 | 290 | 371 | 210 | 266 | 285 | 402 | 218 |
| OPM % | 17% | 25% | 25% | 27% | 26% | 13% | 26% | 30% | 21% | 28% | 25% | 32% | 23% |
| Other Income | 14 | 10 | 16 | 16 | 14 | 7 | 8 | 10 | 19 | 8 | 10 | 12 | 12 |
| Interest | 4 | 3 | 2 | 3 | 22 | 0 | 2 | 7 | 6 | 0 | 4 | 3 | 3 |
| Depreciation | 15 | 15 | 14 | 14 | 15 | 13 | 12 | 10 | 10 | 9 | 9 | 10 | 10 |
| PBT | 146 | 207 | 284 | 309 | 234 | 112 | 285 | 364 | 213 | 265 | 282 | 402 | 218 |
| Tax % | -13% | 27% | 26% | 26% | 34% | 28% | 26% | 26% | 27% | 27% | 26% | 25% | 30% |
| Net Profit | 165 | 151 | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 | 153 |
| EPS in Rs | 50.84 | 46.59 | 64.91 | 70.52 | 47.56 | 24.97 | 65.28 | 82.74 | 48.09 | 59.17 | 64.65 | 92.87 | 47.17 |
Profit & Loss
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 9m | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,334 | 2,275 | 2,320 | 2,455 | 2,947 | 3,002 | 3,574 | 3,901 | 3,918 | 4,206 | 3,374 | 4,290 |
| Expenses | 1,838 | 1,667 | 1,646 | 1,834 | 2,329 | 2,396 | 2,688 | 3,069 | 3,048 | 3,230 | 2,503 | 3,119 |
| Operating Profit | 495 | 608 | 675 | 622 | 618 | 606 | 886 | 832 | 869 | 976 | 871 | 1,171 |
| OPM % | 21% | 27% | 29% | 25% | 21% | 20% | 25% | 21% | 22% | 23% | 26% | 27% |
| Other Income | 64 | 85 | 67 | 18 | 45 | 42 | 38 | 23 | 40 | 47 | 37 | 42 |
| Interest | 6 | 6 | 10 | 5 | 5 | 6 | 6 | 11 | 11 | 27 | 14 | 9 |
| Depreciation | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 56 | 32 | 37 |
| PBT | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 839 | 939 | 862 | 1,167 |
| Tax % | 31% | 34% | 36% | 36% | 31% | 27% | 25% | 27% | 19% | 28% | 26% | 27% |
| Net Profit | 346 | 422 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 856 |
| EPS in Rs | 107 | 130 | 133 | 115 | 129 | 133 | 201 | 177 | 209 | 208 | 196 | 264 |
| Div. Payout % | 28% | 28% | 292% | 35% | 68% | 79% | 157% | 90% | 89% | 123% | 89% | 97% |
Balance Sheet
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 1,196 | 1,619 | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 | 705 | 721 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 4 | 3 | 2 | 1 |
| Other Liabilities | 719 | 515 | 634 | 620 | 708 | 671 | 915 | 940 | 1,187 | 1,081 | 1,015 | 1,049 |
| Total Liabilities | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
| Fixed Assets | 309 | 317 | 286 | 250 | 234 | 206 | 184 | 164 | 170 | 139 | 131 | 163 |
| CWIP | 39 | 35 | 41 | 21 | 15 | 22 | 38 | 44 | 23 | 28 | 41 | 21 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,600 | 1,814 | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 | 1,583 | 1,619 |
| Total Assets | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
Cash Flow
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 426 | 352 | 445 | 415 | 413 | 474 | 863 | 573 | 826 | 470 | 593 | 924 |
| Investing | 28 | 221 | 149 | -19 | 34 | 75 | 7 | -27 | -10 | 1 | -34 | 11 |
| Financing | -105 | -122 | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -861 | -666 | -845 |
| Net Cash Flow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 | 91 |
| Free Cash Flow | 348 | 300 | 401 | 377 | 410 | 423 | 832 | 523 | 781 | 427 | 539 | 893 |
| CFO/OP | 127 | 91 | 103 | 111 | 105 | 102 | 126 | 99 | 121 | 79 | 96 | 105 |
Ratios
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 24 | 21 | 22 | 22 | 20 | 15 | 18 | 20 | 21 | 33 | 21 |
| Inventory Days | 47 | 53 | 71 | 48 | 60 | 68 | 78 | 55 | 48 | 51 | 64 | 51 |
| Days Payable | 148 | 134 | 145 | 156 | 162 | 175 | 237 | 183 | 213 | 193 | 235 | 197 |
| Cash Conversion Cycle | -83 | -57 | -53 | -87 | -79 | -87 | -144 | -110 | -145 | -121 | -138 | -126 |
| Working Capital Days | 4 | 8 | -15 | -23 | -12 | -21 | -39 | -34 | -53 | -32 | -31 | -31 |
| ROCE % | 46% | 45% | 64% | 89% | 73% | 58% | 94% | 110% | 101% | 112% | 104% | 157% |
Documents
1
Clarification sought from Procter & Gamble Hygiene and Health Care Ltd
19 Jun - Exchange has sought clarification from Procter & Gamble Hygiene and Health Care Ltd on June 19, 2026, with reference to Movement in Volume. 19 Jun - Exchange has sought clarification from Procter & Gamble Hygiene and Health Care Ltd on June 19, 2026, with reference to Movement in Volume.
2
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Company has submitted Certificate under regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026 10 Apr - Company has submitted Certificate under regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026
3
Intimation Regarding Ease Of Doing Business - Special Window For Transfer And Dematerialization Of Physical Securities
7 Apr - SEBI special window for re-lodgement of physical shares extended to February 4, 2027. 7 Apr - SEBI special window for re-lodgement of physical shares extended to February 4, 2027.
4
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
6 Apr - Company says it is not a SEBI Large Corporate; outstanding borrowing was nil on March 31, 2026. 6 Apr - Company says it is not a SEBI Large Corporate; outstanding borrowing was nil on March 31, 2026.
5
Closure of Trading Window
27 Mar - Trading window closed for directors/designated employees from April 1, 2026 until 48 hours after audited FY2026 results publication. 27 Mar - Trading window closed for directors/designated employees from April 1, 2026 until 48 hours after audited FY2026 results publication.
3
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 19 Jun 2026
General_Announcements
Frequently Asked Questions about Procter & Gamble Hygiene and Health Care Ltd
What does Procter & Gamble Hygiene and Health Care Ltd do?
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care bran...
Where is Procter & Gamble Hygiene and Health Care Ltd (PGHH) listed?
Procter & Gamble Hygiene and Health Care Ltd is listed on the Indian stock exchanges. It is listed on NSE: PGHH and BSE: 500459. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd operates in the Fast Moving Consumer Goods sector within the Personal Products industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a market capitalisation of approximately ₹29182.20 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Procter & Gamble Hygiene and Health Care Ltd?
The Price-to-Earnings (PE) ratio of Procter & Gamble Hygiene and Health Care Ltd is 34.19. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Procter & Gamble Hygiene and Health Care Ltd?
Over the past 52 weeks, Procter & Gamble Hygiene and Health Care Ltd has traded between a low of ₹8,883.5 and a high of ₹14,540. This range helps investors understand the stock's price volatility and recent trading levels.
Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?
Yes, Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 2.17%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a Return on Equity (ROE) of 71.68%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Procter & Gamble Hygiene and Health Care Ltd on Tapetide?
On Tapetide, you can view Procter & Gamble Hygiene and Health Care Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.